BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1915591)

  • 1. Mapping the xanthine C8-region of the adenosine A1 receptor with computer graphics.
    Van der Wenden EM; Van Galen PJ; IJzerman AP; Soudijn W
    Eur J Pharmacol; 1991 Apr; 206(4):315-23. PubMed ID: 1915591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptors.
    Shamim MT; Ukena D; Padgett WL; Hong O; Daly JW
    J Med Chem; 1988 Mar; 31(3):613-7. PubMed ID: 3346878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
    Shimada J; Suzuki F; Nonaka H; Ishii A
    J Med Chem; 1992 Mar; 35(5):924-30. PubMed ID: 1548682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A steric and electrostatic comparison of three models for the agonist/antagonist binding site on the adenosine A1 receptor.
    van der Wenden EM; Ijzerman AP; Soudijn W
    J Med Chem; 1992 Feb; 35(4):629-35. PubMed ID: 1542091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of 8-cycloalkyl-1,3-dipropylxanthines as antagonists of adenosine receptors.
    Katsushima T; Nieves L; Wells JN
    J Med Chem; 1990 Jul; 33(7):1906-10. PubMed ID: 1694546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the N6-region of the adenosine A1 receptor with computer graphics.
    Van Galen PJ; Leusen FJ; IJzerman AP; Soudijn W
    Eur J Pharmacol; 1989 Mar; 172(1):19-27. PubMed ID: 2714369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthines with C8 chiral substituents as potent and selective adenosine A1 antagonists.
    Peet NP; Lentz NL; Dudley MW; Ogden AM; McCarty DR; Racke MM
    J Med Chem; 1993 Dec; 36(25):4015-20. PubMed ID: 8258823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,3,8-trisubstituted xanthines. Effects of substitution pattern upon adenosine receptor A1/A2 affinity.
    Erickson RH; Hiner RN; Feeney SW; Blake PR; Rzeszotarski WJ; Hicks RP; Costello DG; Abreu ME
    J Med Chem; 1991 Apr; 34(4):1431-5. PubMed ID: 2016719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular simulation of 8-styrylxanthines.
    Mager PP; Reinhardt R; Richter M; Walther H; Rockel B
    Drug Des Discov; 1995 Nov; 13(2):89-107. PubMed ID: 8872454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.
    Shamim MT; Ukena D; Padgett WL; Daly JW
    J Med Chem; 1989 Jun; 32(6):1231-7. PubMed ID: 2724296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Azaxanthine derivatives as antagonists of adenosine receptors.
    Franchetti P; Messini L; Cappellacci L; Grifantini M; Lucacchini A; Martini C; Senatore G
    J Med Chem; 1994 Sep; 37(18):2970-5. PubMed ID: 8071944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.
    Van der Walt MM; Terre'Blanche G; Petzer A; Lourens AC; Petzer JP
    Bioorg Chem; 2013 Aug; 49():49-58. PubMed ID: 23892098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of substituent size upon adenosine receptor A1/A2 affinity of some newly synthesised 8-cycloalkyl xanthines.
    Castagnino E; Salvatori A; Corsano S; Tacchi P; Martini C; Lucacchini A
    Drug Des Discov; 1995 Apr; 12(4):313-21. PubMed ID: 9040991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo analysis of receptor binding affinity data of xanthine adenosine receptor antagonists.
    Dalpiaz A; Gardenghi A; Borea PA
    Arzneimittelforschung; 1995 Mar; 45(3):230-3. PubMed ID: 7741774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative binding orientations of adenosine A1 receptor ligands--a test case for Distributed Multipole Analysis in medicinal chemistry.
    van der Wenden EM; Price SL; Apaya RP; IJzerman AP; Soudijn W
    J Comput Aided Mol Des; 1995 Feb; 9(1):44-54. PubMed ID: 7751869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships in a series of 8-substituted xanthines as bronchodilator and A1-adenosine receptor antagonists.
    Corsano S; Strappaghetti G; Scapicchi R; Lucacchini A; Senatore G
    Arch Pharm (Weinheim); 1995 Sep; 328(9):654-8. PubMed ID: 7487422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The three binding domain model of adenosine receptors: molecular modeling aspects.
    Dooley MJ; Quinn RJ
    J Med Chem; 1992 Jan; 35(2):211-6. PubMed ID: 1732538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8-substituted adenosine and theophylline-7-riboside analogues as potential partial agonists for the adenosine A1 receptor.
    Van der Wenden EM; Hartog-Witte HR; Roelen HC; von Frijtag Drabbe Künzel JK; Pirovano IM; Mathôt RA; Danhof M; Van Aerschot A; Lidaks MJ; IJzerman AP
    Eur J Pharmacol; 1995 Aug; 290(3):189-99. PubMed ID: 7589213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 1,3-diethyl-7-methyl-8-(phenoxymethyl)-xanthine derivatives as novel adenosine A
    Harmse R; van der Walt MM; Petzer JP; Terre'Blanche G
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5951-5955. PubMed ID: 27836398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes.
    Ukena D; Schudt C; Sybrecht GW
    Biochem Pharmacol; 1993 Feb; 45(4):847-51. PubMed ID: 7680859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.